What's Happening?
Ronovo Surgical, a Shanghai-based company, has successfully closed its Series D financing round, securing a total investment of $67 million. This latest funding round was led by Johnson & Johnson's corporate venture capital organization, JJDC. The investment brings Ronovo's total funding to over $100 million in 2025, following a Series C round earlier this year and a $46 million Series B last year. Alongside the funding, Ronovo has entered into a collaboration agreement with Johnson & Johnson to advance the commercialization of its Carina modular robotic surgery platform in China. The Carina platform, unveiled in February 2023, is designed to provide configurable robotic assistance for laparoscopic surgeries across multiple specialties. It has received approval from China's National Medical Products Administration, making it the first modular surgical robotic system in the country to cover four major specialties. Ronovo is also pursuing global expansion, with submissions underway in Europe and South America.
Why It's Important?
The significant investment and collaboration with Johnson & Johnson mark a pivotal moment for Ronovo Surgical, potentially accelerating the adoption of robotic surgery technologies in China and beyond. The Carina platform addresses key challenges in minimally invasive surgeries by offering flexibility and adaptability, which could enhance surgical outcomes and efficiency. This development is particularly relevant as the demand for advanced surgical technologies continues to grow globally. The partnership with a major player like Johnson & Johnson could provide Ronovo with the resources and expertise needed to expand its market presence and drive innovation in the surgical robotics field. The success of this initiative could lead to increased competition and innovation in the medical technology sector, benefiting healthcare providers and patients alike.
What's Next?
Ronovo Surgical plans to leverage the new funding and strategic partnership to accelerate its commercial momentum in China and lay the groundwork for international growth. The company is actively pursuing regulatory approvals in Europe and South America, which could open new markets for the Carina platform. As Ronovo expands its global footprint, it may face competition from established players in the surgical robotics industry. However, its focus on modularity and affordability could give it a competitive edge. The collaboration with Johnson & Johnson is expected to enhance Ronovo's capabilities and market reach, potentially leading to further innovations and partnerships in the future.
